PACS Group (PACS) grants RSUs to chief legal officer in Form 4

Rhea-AI Filing Summary

PACS Group, Inc. reported that its Chief Legal Officer and Secretary received new equity awards in the form of restricted stock units (RSUs). On 12/17/2025, the officer acquired 100,000 shares of common stock at a price of $0 and an additional 21,855 shares at a price of $0, both reported as RSU grants. One RSU award vests in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, and the other vests in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, in each case subject to continued service. Following these transactions, the officer beneficially owns 877,691 shares of common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MITCHELL JOHN TODD

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

FARMINGTON UT 84101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer & Sec.

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		100,000(1)	A	$0	855,836	D
Common Stock	12/17/2025		A		21,855(2)	A	$0	877,691	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the Reporting Person's continued service through the applicable vesting date.

2. Represents RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell	12/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS Group (PACS) report in this Form 4?

The filing reports that the Chief Legal Officer and Secretary of PACS Group, Inc. acquired 100,000 shares and 21,855 shares of common stock at a price of $0 each, reflecting new restricted stock unit (RSU) awards granted on 12/17/2025.

Who is the reporting person in the PACS Group (PACS) Form 4 filing?

The reporting person is an officer of PACS Group, Inc., serving as Chief Legal Officer & Secretary, and is required to report equity transactions as an insider under Section 16 rules.

How many PACS Group shares does the insider beneficially own after these RSU grants?

After the reported transactions, the officer beneficially owns 877,691 shares of PACS Group, Inc. common stock, held directly, as stated in Table I of the filing.

What are the vesting terms of the 100,000 PACS Group RSUs?

The 100,000 RSUs entitle the officer to receive one share of common stock for each RSU, vesting in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service through each vesting date.

What are the vesting terms of the 21,855 PACS Group RSUs?

The 21,855 RSUs entitle the officer to receive one share of common stock for each RSU, vesting in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the officer's continued service through each vesting date.

Were the PACS Group RSU awards reported as being granted for cash consideration?

No cash consideration was reported for these awards. Both the 100,000 and 21,855 common stock entries show a transaction price of $0, consistent with equity compensation in the form of RSUs.